Antimicrobial Treatment Options for Granulomatous Mastitis Caused by Corynebacterium Species
Open Access
- 1 September 2015
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 53 (9) , 2895-2899
Abstract
Corynebacterium species are increasingly recognized as important pathogens in granulomatous mastitis. Currently, there are no published treatment protocols for Corynebacterium breast infections. This study describes antimicrobial treatment options in the context of other management strategies used for granulomatous mastitis. Corynebacterium spp. isolated from breast tissue and aspirate samples stored from 2002 to 2013 were identified and determined to the species level using matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS), 16S RNA sequencing, and rpoB gene targets. The MICs for 12 antimicrobials were performed using Etest for each isolate. Correlations of these with antimicrobial characteristics, choice of antimicrobial, and disease outcome were evaluated. Corynebacterium spp. from breast tissue and aspirate samples were confirmed in 17 isolates from 16 patients. Based on EUCAST breakpoints, Corynebacterium kroppenstedtii isolates ( n = 11) were susceptible to seven antibiotic classes but resistant to β-lactam antibiotics. Corynebacterium tuberculostearicum isolates ( n = 4) were multidrug resistant. Two nonlipophilic species were isolated, Corynebacterium glucuronolyticum and Corynebacterium freneyi , both of which have various susceptibilities to antimicrobial agents. Short-course antimicrobial therapy was common (median, 6 courses per subject; range, 1 to 9 courses). Patients with C. kroppenstedtii presented with a hot painful breast mass and underwent multiple surgical procedures (median, 4 procedures; range, 2 to 6 procedures). The management of Corynebacterium breast infections requires a multidisciplinary approach and includes culture and appropriate sensitivity testing to guide antimicrobial therapy. Established infections have a poor outcome, possibly because adequate concentrations of some drugs will be difficult to achieve in lipophilic granulomata. Lipophilic antimicrobial therapy may offer a therapeutic advantage. The role of immunotherapy has not been defined.Keywords
This publication has 30 references indexed in Scilit:
- Idiopathic ganulomatous mastitisBMJ Case Reports, 2012
- The Genus Corynebacterium and Other Medically Relevant Coryneform-Like BacteriaJournal of Clinical Microbiology, 2012
- Corynebacterium tuberculostearicum: a Potentially Misidentified and Multiresistant Corynebacterium Species Isolated from Clinical SpecimensJournal of Clinical Microbiology, 2012
- Recurrent Breast Abscesses due toCorynebacterium kroppenstedtii, a Human Pathogen Uncommon in Caucasian WomenCase Reports in Infectious Diseases, 2012
- DrugBank 3.0: a comprehensive resource for 'Omics' research on drugsNucleic Acids Research, 2010
- First Description of NOD2 Variant Associated with Defective Neutrophil Responses in a Woman with Granulomatous Mastitis Related to CorynebacteriaJournal of Clinical Microbiology, 2009
- Corynebacterium accolens Isolated from Breast Abscess: Possible Association with Granulomatous MastitisJournal of Clinical Microbiology, 2007
- rpoB Gene Sequencing for Identification of Corynebacterium SpeciesJournal of Clinical Microbiology, 2004
- A clinicopathological review of 34 cases of inflammatory breast disease showing an association between corynebacteria infection and granulomatous mastitisPathology, 2003
- Basic local alignment search toolJournal of Molecular Biology, 1990